Hematologic Cancers News

HEMATOLOGIC CANCER ADVISOR

Hematologic Cancers News

Acute myeloid leukemia

Bexmarilimab Gets Orphan Drug Status for AML

Bexmarilimab is a first-in-class, humanized monoclonal antibody designed to target Clever-1, a receptor on macrophages that leads to tumor growth and metastasis.
Next post in Chronic Lymphocytic Leukemia